Company profile

Ticker
SHPGY, SHPG
Exchange
Website
Employees
Location
Fiscal year end
Former names
Shire Ltd., Shire Pharmaceuticals Group PLC
SEC CIK

SHPGY stock data

(
)

Calendar

1 Nov 18
21 Jan 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Sep 18 Jun 18 Mar 18 Dec 17
Revenue 3.87B 3.92B 3.77B 4.14B
Net income 537.2M 615.5M 550.6M 3.11B
Diluted EPS 0.58 0.67 0.6 3.41
Net profit margin 13.88% 15.70% 14.62% 74.92%
Operating income 955.8M 830.2M 694.3M 850.3M
Net change in cash -66.5M -58M -154.7M 263.1M
Cash on hand 193.2M 259.7M 317.7M 472.4M
Cost of revenue 1.16B 1.11B 1.13B 1.26B
Annual (USD) Dec 17 Dec 16 Dec 15 Dec 14
Revenue 15.16B 11.4B 6.42B 6.02B
Net income 4.27B 327.4M 419M 3.41B
Diluted EPS 4.68 0.42 2.2 5.76
Net profit margin 28.18% 2.87% 6.53% 56.55%
Operating income 2.46B 962.9M 1.42B 1.7B
Net change in cash -56.4M 393.3M -2.85B 743M
Cash on hand 472.4M 528.8M 135.5M 2.98B
Cost of revenue 4.7B 3.82B 969M 979.3M

Financial data from Shire earnings reports

13F holders
Current Prev Q Change
Total holders 0 0 NaN%
Opened positions 0 0 NaN%
Closed positions 0 0 NaN%
Increased positions 0 0 NaN%
Reduced positions 0 0 NaN%
13F shares
Current Prev Q Change
Total value 0 0 NaN%
Total shares 0 0 NaN%
Total puts 0 0 NaN%
Total calls 0 0 NaN%
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: albumin, beneficial, bond, Cambridge, CHF, China, closure, Cloud, complementing, Czech, desmopressin, discipline, extinguishment, Gastrointestinal, headquartered, hosting, Hungary, implementation, Labour, MA, mAb, Ministry, monoclonal, percent, pertinent, premium, profile, repatriation, Republic, repurchase, routine, sanaplasma, sponsor, Switzerland, TAKHZRO, TAKHZYRO, tender, toll, unanimously, unpaid, User, volume, voted, voting, Welfare
Removed: aged, agreed, children, large, occurred, order, SENSIPAR, UK